{"2406.10292": {"publish_time": "2024-06-13", "title": "Automatically Labeling $200B Life-Saving Datasets: A Large Clinical Trial Outcome Benchmark", "paper_summary": "The global cost of drug discovery and development exceeds $200 billion\nannually. The main results of drug discovery and development are the outcomes\nof clinical trials, which directly influence the regulatory approval of new\ndrug candidates and ultimately affect patient outcomes. Despite their\nsignificance, large-scale, high-quality clinical trial outcome data are not\nreadily available to the public. Suppose a large clinical trial outcome dataset\nis provided; machine learning researchers can potentially develop accurate\nprediction models using past trials and outcome labels, which could help\nprioritize and optimize therapeutic programs, ultimately benefiting patients.\nThis paper introduces Clinical Trial Outcome (CTO) dataset, the largest trial\noutcome dataset with around 479K clinical trials, aggregating outcomes from\nmultiple sources of weakly supervised labels, minimizing the noise from\nindividual sources, and eliminating the need for human annotation. These\nsources include large language model (LLM) decisions on trial-related\ndocuments, news headline sentiments, stock prices of trial sponsors, trial\nlinkages across phases, and other signals such as patient dropout rates and\nadverse events. CTO's labels show unprecedented agreement with supervised\nclinical trial outcome labels from test split of the supervised TOP dataset,\nwith a 91 F1.", "paper_summary_zh": "\u5168\u7403\u85e5\u7269\u767c\u73fe\u548c\u958b\u767c\u7684\u6210\u672c\u6bcf\u5e74\u8d85\u904e 2000 \u5104\u7f8e\u5143\u3002\u85e5\u7269\u767c\u73fe\u548c\u958b\u767c\u7684\u4e3b\u8981\u6210\u679c\u662f\u81e8\u5e8a\u8a66\u9a57\u7684\u7d50\u679c\uff0c\u5b83\u76f4\u63a5\u5f71\u97ff\u65b0\u85e5\u5019\u9078\u8005\u7684\u6cd5\u898f\u6838\u51c6\uff0c\u4e26\u6700\u7d42\u5f71\u97ff\u60a3\u8005\u7684\u7d50\u679c\u3002\u5118\u7ba1\u5b83\u5011\u5f88\u91cd\u8981\uff0c\u4f46\u5927\u578b\u3001\u9ad8\u54c1\u8cea\u7684\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u6578\u64da\u4e26\u4e0d\u5bb9\u6613\u8b93\u516c\u773e\u53d6\u5f97\u3002\u5047\u8a2d\u63d0\u4f9b\u4e86\u5927\u578b\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u6578\u64da\u96c6\uff1b\u6a5f\u5668\u5b78\u7fd2\u7814\u7a76\u4eba\u54e1\u6709\u53ef\u80fd\u4f7f\u7528\u904e\u53bb\u7684\u8a66\u9a57\u548c\u7d50\u679c\u6a19\u7c64\u958b\u767c\u6e96\u78ba\u7684\u9810\u6e2c\u6a21\u578b\uff0c\u9019\u6709\u52a9\u65bc\u512a\u5148\u8003\u616e\u548c\u6700\u4f73\u5316\u6cbb\u7642\u8a08\u756b\uff0c\u6700\u7d42\u4f7f\u60a3\u8005\u53d7\u76ca\u3002\u672c\u6587\u4ecb\u7d39\u4e86\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c (CTO) \u6578\u64da\u96c6\uff0c\u9019\u662f\u6700\u5927\u7684\u8a66\u9a57\u7d50\u679c\u6578\u64da\u96c6\uff0c\u5305\u542b\u7d04 479K \u500b\u81e8\u5e8a\u8a66\u9a57\uff0c\u5f59\u7e3d\u4e86\u4f86\u81ea\u591a\u500b\u4f86\u6e90\u7684\u5f31\u76e3\u7763\u6a19\u7c64\u7684\u7d50\u679c\uff0c\u6700\u5927\u9650\u5ea6\u5730\u6e1b\u5c11\u4e86\u4f86\u81ea\u500b\u5225\u4f86\u6e90\u7684\u96dc\u8a0a\uff0c\u4e26\u6d88\u9664\u4e86\u4eba\u5de5\u8a3b\u89e3\u7684\u9700\u8981\u3002\u9019\u4e9b\u4f86\u6e90\u5305\u62ec\u5927\u578b\u8a9e\u8a00\u6a21\u578b (LLM) \u5c0d\u8a66\u9a57\u76f8\u95dc\u6587\u4ef6\u7684\u6c7a\u5b9a\u3001\u65b0\u805e\u6a19\u984c\u60c5\u7dd2\u3001\u8a66\u9a57\u8d0a\u52a9\u5546\u7684\u80a1\u7968\u50f9\u683c\u3001\u8de8\u968e\u6bb5\u8a66\u9a57\u9023\u7d50\uff0c\u4ee5\u53ca\u5176\u4ed6\u4fe1\u865f\uff0c\u4f8b\u5982\u60a3\u8005\u8f1f\u5b78\u7387\u548c\u4e0d\u826f\u4e8b\u4ef6\u3002CTO \u7684\u6a19\u7c64\u986f\u793a\u51fa\u8207\u4f86\u81ea\u76e3\u7763\u5f0f TOP \u6578\u64da\u96c6\u6e2c\u8a66\u5206\u5272\u7684\u76e3\u7763\u5f0f\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u6a19\u7c64\u524d\u6240\u672a\u6709\u7684\u543b\u5408\u5ea6\uff0cF1 \u70ba 91\u3002", "author": "Chufan Gao et.al.", "authors": "Chufan Gao, Jathurshan Pradeepkumar, Trisha Das, Shivashankar Thati, Jimeng Sun", "id": "2406.10292v1", "paper_url": "http://arxiv.org/abs/2406.10292v1", "repo": "null"}}